BridgeBio Pharma, Inc. (BBIO) Ownership

$32.64

$0.73 (-2.19%)
Last update: 09:42 AM EST
Day's range
$31.77
Day's range
$33.39

BridgeBio Pharma, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VIKING GLOBAL INVESTORS LP 05/15/2025 22.06 M $762.45 M   -12.20% 11.60%
KOHLBERG KRAVIS ROBERTS & CO. L.P. 05/15/2025 19.26 M $665.85 M   -23.75% 10.13%
VANGUARD GROUP INC 05/09/2025 14.90 M $515.10 M   -1.18% 7.84%
BLACKROCK, INC. 05/02/2025 13.36 M $461.77 M   -2.57% 7.02%
JANUS HENDERSON GROUP PLC 05/15/2025 7.17 M $251.73 M   46.13% 3.77%
AISLING CAPITAL MANAGEMENT LP 05/13/2025 6.07 M $209.78 M   0.00% 3.19%
STATE STREET CORP 05/15/2025 5.75 M $198.76 M   -7.00% 3.02%
FARALLON CAPITAL MANAGEMENT LLC 05/15/2025 5.73 M $198.12 M   36.62% 3.01%
CAPITAL RESEARCH GLOBAL INVESTORS 05/12/2025 4.67 M $161.35 M   32.34% 2.45%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 05/15/2025 3.80 M $131.38 M   0.00% 2.00%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 3.50 M $121.12 M   2.49% 1.84%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 3.11 M $107.36 M   -11.41% 1.63%
LAURION CAPITAL MANAGEMENT LP 05/15/2025 2.98 M $102.96 M   -20.39% 1.57%
CITADEL ADVISORS LLC 05/15/2025 2.93 M $101.33 M   133.48% 1.54%
DEEP TRACK CAPITAL, LP 05/15/2025 2.80 M $96.80 M   241.81% 1.47%
ALLIANCEBERNSTEIN L.P. 05/15/2025 2.68 M $92.79 M   -3.94% 1.41%
GOLDMAN SACHS GROUP INC 05/16/2025 2.22 M $76.86 M   9.24% 1.17%
INVESCO LTD. 05/12/2025 2.21 M $76.27 M   147.02% 1.16%
FMR LLC 05/12/2025 2.18 M $75.22 M   34.18% 1.14%
PICTET ASSET MANAGEMENT HOLDING SA 05/05/2025 2.09 M $72.42 M   15.65% 1.10%
CORMORANT ASSET MANAGEMENT, LP 05/15/2025 2.00 M $69.14 M   25.00% 1.05%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 05/15/2025 1.89 M $65.26 M   0.10% 0.99%
SC US (TTGP), LTD. 05/14/2025 1.86 M $64.31 M   0.00% 0.98%
ENSIGN PEAK ADVISORS, INC 05/14/2025 1.85 M $63.96 M   -6.34% 0.97%
WOODLINE PARTNERS LP 05/15/2025 1.63 M $56.20 M   -26.49% 0.86%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2025 1.50 M $51.87 M   100.00% 0.79%
MORGAN STANLEY 05/15/2025 1.50 M $51.81 M   19.73% 0.79%
CITIGROUP INC 05/12/2025 1.40 M $48.45 M   -8.92% 0.74%
NORTHERN TRUST CORP 05/13/2025 1.29 M $44.49 M   -2.75% 0.68%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 1.28 M $44.33 M   -1.88% 0.67%
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 1.16 M $40.27 M   17.53% 0.61%
PRINCIPAL FINANCIAL GROUP INC 04/28/2025 1.15 M $39.70 M   9.35% 0.60%
EMERALD ADVISERS, LLC 05/01/2025 1.15 M $39.60 M   -0.47% 0.60%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 05/15/2025 1.13 M $39.05 M   100.00% 0.59%
ASSENAGON ASSET MANAGEMENT S.A. 04/15/2025 1.12 M $38.75 M   4,544.62% 0.59%
AMERIPRISE FINANCIAL INC 05/14/2025 1.04 M $36.02 M   140.59% 0.55%
AMERICAN CENTURY COMPANIES INC 05/13/2025 1.03 M $35.52 M   1.16% 0.54%
05/15/2025 962.88 K $33.29 M   7.17% 0.51%
BANK OF AMERICA CORP /DE/ 05/15/2025 946.85 K $32.73 M   117.69% 0.50%
PRIMECAP MANAGEMENT CO/CA/ 05/09/2025 913.20 K $31.57 M   -0.25% 0.48%
PFM HEALTH SCIENCES, LP 05/15/2025 908.14 K $31.39 M   212.89% 0.48%
LORD, ABBETT & CO. LLC 05/13/2025 857.92 K $29.66 M   100.00% 0.45%
TWO SIGMA INVESTMENTS, LP 05/15/2025 843.32 K $29.15 M   253.54% 0.44%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2025 800.08 K $27.66 M   100.00% 0.42%
FRONTIER CAPITAL MANAGEMENT CO LLC 05/15/2025 769.30 K $26.59 M   -28.49% 0.40%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2025 760.47 K $26.29 M   5,856.56% 0.40%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 739.70 K $25.57 M   -39.58% 0.39%
SOFINNOVA INVESTMENTS, INC. 05/15/2025 734.23 K $25.38 M   100.00% 0.39%
EMERALD MUTUAL FUND ADVISERS TRUST 05/01/2025 724.35 K $25.04 M   -0.07% 0.38%
FIRST TURN MANAGEMENT, LLC 05/15/2025 656.70 K $22.70 M   45.19% 0.35%

BridgeBio Pharma, Inc. institutional Ownership - FAQ's

During the previous two years, 359 institutional investors and hedge funds held shares of BridgeBio Pharma, Inc.. The most heavily invested institutionals were:

VIKING GLOBAL INVESTORS LP: 22.06 M

Kohlberg Kravis Roberts & Co. L.P.: 19.26 M

VANGUARD GROUP INC: 14.9 M

BlackRock, Inc.: 13.36 M

JANUS HENDERSON GROUP PLC: 7.17 M

Aisling Capital Management LP: 6.07 M

97.37% of BridgeBio Pharma, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 200.39 M shares in the last 24 months. This purchase volume represents approximately $6.69 B in transactions.